Scale Up & Tech Transfer

Mar 02, 2009
BioPharm International
Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.
Mar 02, 2009
BioPharm International
The future of therapeutic MAbs lies in the development of economically feasible downstream processes.
Mar 01, 2009
BioPharm International
By BioPharm International Editors
Data on the performance and variability of different formats.
Mar 01, 2009
BioPharm International
A close-up look at Pfizer's biotherapeutics plant in Shanbally, Ireland.
Mar 01, 2009
BioPharm International
Robust packing procedures can improve process performance and increase resin lifetime.
Jan 02, 2009
BioPharm International
With virus-based production, vaccines can be available in 10-12 weeks.
Jan 01, 2009
BioPharm International
How to ensure smooth technology transfers.
Sep 23, 2008
In biomanufacturing today, there is increasing focus on improving process development. The goal is to accelerate development and reduce costs, without compromising the ability to scale up to a robust commercial process later on.
Sep 01, 2008
BioPharm International
By BioPharm International Editors
How to implement a risk-based approach to eliminating viruses.
Aug 01, 2008
BioPharm International
By BioPharm International Editors
A review of some recent contributions in process chromatography.
native1_300x100
lorem ipsum